Subrahmanya Vallabhapurapu

627 total citations
21 papers, 476 citations indexed

About

Subrahmanya Vallabhapurapu is a scholar working on Molecular Biology, Immunology and Epidemiology. According to data from OpenAlex, Subrahmanya Vallabhapurapu has authored 21 papers receiving a total of 476 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 11 papers in Immunology and 5 papers in Epidemiology. Recurrent topics in Subrahmanya Vallabhapurapu's work include Phagocytosis and Immune Regulation (9 papers), Erythrocyte Function and Pathophysiology (5 papers) and Autophagy in Disease and Therapy (5 papers). Subrahmanya Vallabhapurapu is often cited by papers focused on Phagocytosis and Immune Regulation (9 papers), Erythrocyte Function and Pathophysiology (5 papers) and Autophagy in Disease and Therapy (5 papers). Subrahmanya Vallabhapurapu collaborates with scholars based in United States, United Kingdom and Spain. Subrahmanya Vallabhapurapu's co-authors include Xiaoyang Qi, Zhengtao Chu, Robert S. Franco, Mahaboob Khan Sulaiman, Victor Blanco, Sivakumar Vallabhapurapu, Laura Wolgamott, Joseph Tcherkezian, Philippe P. Roux and Sejeong Shin and has published in prestigious journals such as Nature Communications, The Journal of Experimental Medicine and PLoS ONE.

In The Last Decade

Subrahmanya Vallabhapurapu

20 papers receiving 471 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Subrahmanya Vallabhapurapu United States 12 318 135 101 76 58 21 476
Lai Sum Leoh United States 11 267 0.8× 83 0.6× 65 0.6× 103 1.4× 31 0.5× 14 519
Paul Cheng Hong Kong 9 229 0.7× 67 0.5× 205 2.0× 64 0.8× 36 0.6× 15 535
Christin A. Hamilton United States 7 320 1.0× 136 1.0× 53 0.5× 100 1.3× 29 0.5× 9 506
Águeda Martínez‐Barriocanal Spain 13 163 0.5× 210 1.6× 81 0.8× 91 1.2× 18 0.3× 20 437
Felipe Vences‐Catalán United States 12 228 0.7× 235 1.7× 55 0.5× 110 1.4× 23 0.4× 17 505
Alexander Buffone United States 13 319 1.0× 222 1.6× 47 0.5× 73 1.0× 19 0.3× 17 565
Alexei Shir Israel 12 547 1.7× 187 1.4× 79 0.8× 148 1.9× 27 0.5× 20 738
Bushra Samad United States 10 316 1.0× 419 3.1× 88 0.9× 217 2.9× 45 0.8× 14 766
Sonia Brockway United States 7 300 0.9× 167 1.2× 91 0.9× 171 2.3× 29 0.5× 8 472
Emily N. Arner United States 8 260 0.8× 213 1.6× 148 1.5× 175 2.3× 38 0.7× 10 567

Countries citing papers authored by Subrahmanya Vallabhapurapu

Since Specialization
Citations

This map shows the geographic impact of Subrahmanya Vallabhapurapu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Subrahmanya Vallabhapurapu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Subrahmanya Vallabhapurapu more than expected).

Fields of papers citing papers by Subrahmanya Vallabhapurapu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Subrahmanya Vallabhapurapu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Subrahmanya Vallabhapurapu. The network helps show where Subrahmanya Vallabhapurapu may publish in the future.

Co-authorship network of co-authors of Subrahmanya Vallabhapurapu

This figure shows the co-authorship network connecting the top 25 collaborators of Subrahmanya Vallabhapurapu. A scholar is included among the top collaborators of Subrahmanya Vallabhapurapu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Subrahmanya Vallabhapurapu. Subrahmanya Vallabhapurapu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vallabhapurapu, Subrahmanya, Harold W. Davis, Eric P. Smith, et al.. (2025). TLR2-Bound Cancer-Secreted Hsp70 Induces MerTK-Mediated Immunosuppression and Tumorigenesis in Solid Tumors. Cancers. 17(3). 450–450. 2 indexed citations
2.
Sarma, P.N., Collin Wetzel, Nicholas A. Clark, et al.. (2024). Coordinated Targeting of S6K1/2 and AXL Disrupts Pyrimidine Biosynthesis in PTEN-Deficient Glioblastoma. Cancer Research Communications. 4(8). 2215–2227. 2 indexed citations
3.
Vallabhapurapu, Subrahmanya, et al.. (2024). 26. The Role of Macrophages In Mediating Radiation-induced Fibrosis. Plastic & Reconstructive Surgery Global Open. 12(S4). 18–19. 1 indexed citations
4.
Wang, Chenran, Syn Kok Yeo, Subrahmanya Vallabhapurapu, et al.. (2021). Autophagy mediated lipid catabolism facilitates glioma progression to overcome bioenergetic crisis. British Journal of Cancer. 124(10). 1711–1723. 15 indexed citations
5.
Davis, Harold W., et al.. (2021). SapC–DOPS as a Novel Therapeutic and Diagnostic Agent for Glioblastoma Therapy and Detection: Alternative to Old Drugs and Agents. Pharmaceuticals. 14(11). 1193–1193. 3 indexed citations
6.
Davis, Harold W., et al.. (2021). Targeting of elevated cell surface phosphatidylserine with saposin C-dioleoylphosphatidylserine nanodrug as individual or combination therapy for pancreatic cancer. World Journal of Gastrointestinal Oncology. 13(6). 550–559. 2 indexed citations
7.
Davis, Harold W., Zhengtao Chu, Subrahmanya Vallabhapurapu, et al.. (2020). Enhanced Efficacy of Combination of Gemcitabine and Phosphatidylserine-Targeted Nanovesicles against Pancreatic Cancer. Molecular Therapy. 28(8). 1876–1886. 16 indexed citations
8.
Vaeth, Martin, Subrahmanya Vallabhapurapu, Stefan Klein-Heßling, et al.. (2020). Lack of NFATc1 SUMOylation prevents autoimmunity and alloreactivity. The Journal of Experimental Medicine. 218(1). 22 indexed citations
9.
Davis, Harold W., Subrahmanya Vallabhapurapu, Zhengtao Chu, et al.. (2020). Biotherapy of Brain Tumors with Phosphatidylserine-Targeted Radioiodinated SapC-DOPS Nanovesicles. Cells. 9(9). 1960–1960. 6 indexed citations
10.
Davis, Harold W., Subrahmanya Vallabhapurapu, Zhengtao Chu, et al.. (2019). Enhanced phosphatidylserine-selective cancer therapy with irradiation and SapC-DOPS nanovesicles. Oncotarget. 10(8). 856–868. 22 indexed citations
11.
Sulaiman, Mahaboob Khan, Zhengtao Chu, Victor Blanco, et al.. (2015). SapC-DOPS nanovesicles induce Smac- and Bax-dependent apoptosis through mitochondrial activation in neuroblastomas. Molecular Cancer. 14(1). 78–78. 13 indexed citations
12.
Vallabhapurapu, Subrahmanya, Victor Blanco, Mahaboob Khan Sulaiman, et al.. (2015). Variation in human cancer cell external phosphatidylserine is regulated by flippase activity and intracellular calcium. Oncotarget. 6(33). 34375–34388. 100 indexed citations
13.
Qi, Xiaoyang, Victor Blanco, Zhengtao Chu, et al.. (2015). P-040 Phosphatidylserine Targeted Therapy of Pancreatic Cancer Using SapC-DOPS Nanovesicles. Annals of Oncology. 26. iv11–iv11. 1 indexed citations
14.
Vallabhapurapu, Subrahmanya, Sunil K. Noothi, Charles H. Lawrie, et al.. (2015). Transcriptional repression by the HDAC4–RelB–p52 complex regulates multiple myeloma survival and growth. Nature Communications. 6(1). 8428–8428. 51 indexed citations
15.
16.
Malek, Ehsan, et al.. (2014). Bortezomib induces AMPK-dependent autophagosome formation uncoupled from apoptosis in drug resistant cells. Oncotarget. 5(23). 12358–12370. 27 indexed citations
17.
Noothi, Sunil K., Subrahmanya Vallabhapurapu, Subrahmanya Vallabhapurapu, et al.. (2013). Transcriptional Repression of Bim by a Novel YY1-RelA Complex Is Essential for the Survival and Growth of Multiple Myeloma. PLoS ONE. 8(7). e66121–e66121. 23 indexed citations
18.
Shin, Sejeong, Laura Wolgamott, Joseph Tcherkezian, et al.. (2013). Glycogen synthase kinase-3β positively regulates protein synthesis and cell proliferation through the regulation of translation initiation factor 4E-binding protein 1. Oncogene. 33(13). 1690–1699. 87 indexed citations
19.
Vallabhapurapu, Subrahmanya. (2013). Regulation of the Alternative NF-κb Pathway and Its Role in Cancer. Journal of Cancer Science & Therapy. 5(5). 2 indexed citations
20.
Bonadies, Nicolas, et al.. (2009). PU.1 is regulated by NF-κB through a novel binding site in a 17 kb upstream enhancer element. Oncogene. 29(7). 1062–1072. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lai Sum Leoh Breakdown of academic impact, for papers by Paul Cheng Breakdown of academic impact, for papers by Christin A. Hamilton Breakdown of academic impact, for papers by Águeda Martínez‐Barriocanal Breakdown of academic impact, for papers by Felipe Vences‐Catalán Breakdown of academic impact, for papers by Alexander Buffone Breakdown of academic impact, for papers by Alexei Shir Breakdown of academic impact, for papers by Bushra Samad Breakdown of academic impact, for papers by Sonia Brockway Breakdown of academic impact, for papers by Emily N. Arner
Rankless by CCL
2026